Rucaparib Camsylate is a camysylate salt form of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib, an anti-cancer agent indicated for the treatment of recurrent ovarian, fallopian tube, and peritoneal… Read more
Rucaparib Camsylate is a camysylate salt form of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib, an anti-cancer agent indicated for the treatment of recurrent ovarian, fallopian tube, and peritoneal cancers in patients with specific genetic mutations. Accurate analytical assessment of this complex therapeutic requires high-quality reference materials to ensure safety and efficacy throughout the drug development lifecycle. This category contains a comprehensive selection of Rucaparib Camsylate reference standards, including the active pharmaceutical ingredient, related impurities, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control testing. By utilizing these precise standards, researchers can effectively identify and quantify degradation products and metabolites, facilitating compliance with regulatory requirements and supporting the reliable characterization of this targeted oncology treatment in various analytical matrices.